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ABSTRACT 
Objective: To study the antidiabetic, anticholinergic and antioxidant activity of leaf extracts of Ochna obtusata DC. using in vitro methods. 
Methods: Alcoholic extract and a decoction of Ochna obtusata DC. leaf was screened for antidiabetic, anticholinergic and antioxidant activity by 
using in vitro methods. Total phenolic and total antioxidant capacity of Ochna obtusata DC. leaf extracts were quantified as gallic acid equivalents, 
using the spectrophotometric method. 
Results: The ethanol extract and water decoction showed strong inhibition to 1,1-diphenyl-2-picrylhydrazyl radical (IC50 0.3±0.01 µg/ml, 90±5.1 
µg/ml), Nitric Oxide (IC50 of 43±1 µg/ml, 82±1 µg/ml) hydrogen peroxide (IC50 of 45±2.1 µg/ml, 92±1.3 µg/ml), hydroxyl radical (IC50 of 22±2.3 
µg/ml, above 200), lipid peroxidation (IC50 of 4.37±0.5 µg/ml, 1.68±0.3 µg/ml)equivalents of gallic acid (EGA), whereas the Acetylcholinesterase 
(IC50 of 0.5±0.2, 40±2.12) and α-Glucosidase IC50 of 3.5±.04 µg/ml, 45±3.03 µg/ml against the standard drug (acarbose equivalents) respectively. 
The present investigation revealed that the alcoholic extract of Ochna obtusata DC (except lipid peroxide) is effective than water decoction. 
Conclusion: The present observations suggest that Ochna. obtusata DC leaves may be considered as a new source for anticholinergic, antidiabetic 
and antioxidant constituents for therapeutic use.  
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INTRODUCTION 
The genus Ochna (Ochnaceae) represented by more than 80 species 
distributed in tropical Asia, Africa, and America [1]. Ochna obtusata 
DC. (Telugu: Kukkamogi, Erravuddi; English: Golden champak) is a 
medium-sized tree widely grown throughout the hilly tracts of South 
India [2]. It is one of the potential medicinal plants and used for the 
treatment of various ailments in Indian traditional system of 
medicine. The roots of Ochna obtusata DC. were used in the treatment of 
menstrual complaints, asthma, constipation, poisonous bites, and also 
showed very strong analgesic and anti-inflammatory activity [3-4]. The 
stem bark was used for bone fractures, swellings, and as digestive tonic 
[5-8]. The leaves were used to cure, fever, inflammation, cholera, 
dysentery, dry cough, bronchitis, sores, cancer, lumbago, snake bite, 
menstrual complaints, asthma and epilepsy [9-11]. 
In view of its wide importance in folklore as well as an Ayurvedic 
system of medicine, Ochna obtusata DC. has been undertaken for 
antioxidant and other biological studies using in vitro assays. Free 
radicals or reactive oxygen species are implicated in various 
immune-modulatory diseases have attracted great attention in 
recent years. They are mainly derived from oxygen (reactive oxygen 
species/ROS) and nitrogen (reactive nitrogen species/RNS) in the 
human body by various endogenous systems, when exposed to 
different physicochemical conditions or pathophysiological states 
[12]. Free radicals can adversely alter lipids, protein and DNA and 
have been implicated in the etiology of several human diseases like 
diabetes, oxidative stress including Alzheimer’s disease (AD) [13]. 
Several experimental pieces of evidence support the involvement of 
free radicals in inducing diabetes, and mainly in the development of 
diabetic complications [14], in addition to cardiovascular diseases, 
autoimmune and neurodegenerative disorders, inflammations, etc 
[15]. Hence, antioxidants may offer resistance to oxidative stress by 
scavenging free radicals, inhibiting lipid peroxidation, etc, and they 
prevent deadly diseases. Many commercial antioxidants namely, 
butylated hydroxyl toluene (BHT), L-Ascorbic acid and α-tocopherol 
are available, but they show side effects under certain conditions 
[16]. Several natural products from dietary components such as β-
carotene, vitamin C, E and medicinal plant products serve as 
antioxidants which are believed to be non-toxic and less side-effects [17]. 
From the thorough review of the literature, it was noticed that 
Ochna obtusata DC.leaves show multiple beneficial activities which 
might be linked with antioxidant properties directly hither to not 
evaluated so far. Hence, the present investigation was carried out to 
evaluate the extracts obtained from the leaves of Ochna obtusata DC. 
for antioxidant, anti-acetyl cholinesterase and anti-α-glucosidase 
properties. To combat the side effects of synthetic drugs, the natural 
products especially, medicinal plants serve as a good resource for 
such beneficial activities. An acetylcholinesterase inhibitor (AChEI) 
or anti-cholinesterase is a chemical or a drug that inhibits 
the acetylcholinesterase enzyme from breaking down acetylcholine, 
thereby enhancing the level and duration of action of 
the neurotransmitter acetylcholine. Acetylcholinesterase inhibitors 
are used as weapons in the form of nerve agents, as insecticides and 
applied medicinally to treat myasthenia gravis (increase 
neuromuscular transmission), glaucoma, postural tachycardia 
syndrome, as an antidote to anticholinergic poisoning, reverse the 
effect of non-depolarising muscle relaxants, neuropsychiatric 
symptoms of Alzheimer's disease, particularly apathy, increases 
chances of lucid dreaming (by prolonging REM sleep), Lewy Body 
dementia and Parkinson's disease. AChEIs are primarily used to 
treat the cognitive (memory and learning deficits) symptoms 
of dementia. These symptoms are attenuated due to the role of 
acetylcholine in cognition in the CNS.  
The report also suggests that AChEIs may attenuate psychotic 
symptoms (especially visual hallucinations) in Parkinson's disease 
in addition to treat cognitive impairments in patients 
with schizophrenia [18-24]. Alpha-glucosidase inhibitors used 
for diabetes mellitus type 2 which are oral anti-diabetic drugs which 
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prevents the digestion of carbohydrates (such as starch and table 
sugar) into simple sugars (monosaccharides). Hence, α-glucosidase 
inhibitors play an important role in controlling blood sugar 
particularly postprandial hyperglycemia [25]. So the present 
investigation finds importance in the treatment of several 
neurogenreic diseases, diabetes and in oxidative stress with Ochna 
obtusata DC. in addition to providing scientific validation of the 
traditional usage. 
MATERIALS AND METHODS 
Plant material 
The leaves of Ochna obtusata DC.were collected from hilly tracts of 
Tirumala, Chittoor district, Andhra Pradesh, India. The voucher 
specimen (#27034) has been deposited in the herbarium at Sri 
Krishnadevaraya University (SKU), Ananthapuramu, India. The 
plant material was identified by using authenticated regional 
floras [26-30].  
Preparation of plant extracts 
The leaves were washed with distilled water and dried in the shade 
at room temperature. Ten grams of shade dried, pounded plant 
material was taken and soaked in the ethanol or distilled water and 
boiled carefully at 50ᵒ C for 3 h and the extracts were filtered and 
the filtrate was concentrated, stored at low temperature and used 
for the assays.  
Quantification of total polyphenols  
Total phenol content of leaf extracts was quantified using Folin-
Ciocalteau reagent [31] gallic acid was used as standard drug. The 
ability to reduce the phosphotungstate-phosphomolybdate complex 
was considered and the resultant color was measured using gallic 
acid standard. The colorimetric method is based on the reduction by 
phenolics to blue colored products in alkaline conditions. Ten µl of 
alcoholic extract or decoction were taken and 125 µl of Folin-
ciocalteau reagent was added. After 10 min 300 µl of 20 % aqueous 
sodium carbonate solution was made up to 1 ml with distilled water 
and the reaction mixture was incubated in dark for 2 h. The 
absorbance was recorded spectrophotometrically at 725 nm and the 
total phenol concentration (TPC) was quantified from the calibration 
curve prepared, in the same conditions with gallic acid (standard) 
and expressed in milligrams of gallic acid equivalent (GAE)/g of dry 
plant extract.  
Total antioxidant capacity 
For the total antioxidant capacity assay, 10 µl of the extract was mixed 
with1 ml of reagent solution (0.6 M sulfuric acid, 28 mM sodium 
phosphate and 4 mM ammonium molybdate). The tubes were capped 
and incubated in a thermal block at 95 °C for 90 min. After cooling to 
room temperature, the absorbance of the aqueous solution of each 
was measured at 695 nm against a blank. Ascorbic acid was used as 
the standard and the total antioxidant capacity was expressed as 
equivalents of ascorbic acid. The antioxidant capacity of extracts was 
estimated by the phospho molybdenum-reducing assay [32]. 
DPPH (1, 1-diphenyl-2-picrylhydrazyl) scavenging activity 
The free-radical scavenging activity of plant extracts was measured 
by the decrease in absorbance of a methanol solution of DPPH [33]. 
A stock solution of DPPH (33 mg/l) was prepared in methanol and 5 
ml of this stock solution was added to 100 µl of the plant extract 
solution at a concentration of 1000 µg/ml. After 30 min, absorbance 
was measured at 517 nm and compared with the ascorbic acid as a 
standard (50µg/ml). Scavenging activity was expressed as the 
percentage inhibition. 
Hydrogen peroxide scavenging activity 
This was performed by the ferrous ion oxidation-xylenol orange 
(FOX) assay [34]. One volume of reagent 2 was added to 9 volumes 
of reagent I Reagent 1 (4.4 mM butylated hydroxytoluene (BHT) in 
HPLC-grade methanol) reagent 2 (1 mM xylenol orange plus 2.56 
mM ammonium ferrous sulphate in 250 mM H2SO4) to make the 
working FOX reagent. The extracts of different concentrations were 
mixed with 10 µl of 40 mM H2O2 and incubated in dark for ten 
minutes, and 1 ml of xylenol orange reagent was added. The 
disappearance of color was considered as a positive reaction, and 
the test samples were spectrophotometrically read at 548 nm and 
compared with a standard antioxidant (vitamin C).  
Hydroxyl radical scavenging activity 
Hydroxyl radical (OH) scavenging activity was measured by 
studying the competition between deoxyribose and test compounds 
for hydroxyl radical generated by the Fe3+–ascorbate-EDTA–H2O2 
system according to the method [35] Arouma et al., 1987 O.I. 
Arouma, M. Grootveld and B. Halliwell, The role of iron in ascorbate-
dependent deoxyribose degradation, J. Inorg. Biochem. (1987), pp. 
289–299. Depending upon the use of EDTA, this method comprised 
non-site and site-specific scavenging of OH radicals. For non-site 
specific hydroxyl radical scavenging assay, the Haber-Weiss reaction 
mixture (1 ml) contained 2-deo-xyribose (10 mM), Fe(III) chloride 
(10 mM), EDTA (1 mM), and H2O2 (10 mM) without or with the test 
extracts (10–100 μg/ml) in 50 mM potassium phosphate buffer, pH 
7.4. EDTA was replaced with the same amount of buffer in case of 
site-specific hydroxyl radical scavenging assay. The reaction was 
triggered by adding ascorbic acid (1 mM) which served as a reducing 
agent by reducing Fe3+ to Fe2+ ions and subsequent incubation of the 
mixture for 1 h at 37 °C. Solutions of Fe(III) chloride, ascorbic acid 
and H2O2 were prepared in distilled water just prior to use. To 1 ml 
solution of above mixture, TBA in 25 mM NaOH (1 ml, 0.5%) and 
TCA (1 ml, 10% w/v aqueous solution) were added. The mixture 
was heated for 90 min on a water bath at 80 °C and the amount of 
pink chromogen produced was spectrophotometrically measured at 
532 nm. Ascorbic acid was used as a standard compound.  
Nitric oxide (NO) scavenging activity 
Nitric oxide scavenging activity was measured by spectro-photometric 
method [36, 37]. Sodium nitroprusside (10 mM) in phosphate buffered 
saline was mixed with a concentration of the extract (100µg) prepared 
in methanol and incubated at 25 °C for 30 min. A control reaction 
without plant extracts or standard compound but with an equivalent 
amount of methanol was taken has been considered as a complete 
reaction. After 30 min, 1.5 ml of the incubated solution was removed 
and diluted with 1.5 ml of Griess reagent (1%sulphanilamide, 2% 
phosphoric acid and 0.1% N 1-naphthylethylenediamine 
dihydrochloride). The absorbance of the chromophore formed was 
measured at 546 nm and percentage scavenging activity was 
measured with reference to standard (ascorbic acid). 
Anti-lipid peroxidation assay in rat liver tissue homogenate 
Preparation of liver homogenate 
Normal albino rat of the Wistar strain (250 g) was sacrificed and 
perfused the liver with 0.15KCl and homogenized at 0–4 °C and 
centrifuged at 800×g for 15 min, and the clear cell-free supernatant 
was used for in vitro lipid peroxidation assay.  
The protective effect of the extracts was determined by mixing 
different concentrations of the extracts with 0.15 M KCl and rat liver 
homogenate. Peroxidation was initiated by adding 100 μl of 10 mM 
ferric chloride. After incubation at 37 °C for 30 min., lipid peroxidation 
was monitored by the formation of thiobarbituric acid reactive 
substances (TBARS). The amount of malondialdehyde formed was 
estimated by spectrophotometrically at 548. TBARS were estimated by 
adding 2 ml of ice-cold HCl (0.25 N) containing 15% trichloroacetic 
acid (TCA), 0.5% TBA, and 0.5% butylated hydroxytoluene (BHT) to 
the reaction mixture, followed by heating at 80 °C for 60 min. 
AChE inhibition assay 
Purified enzyme Acetylcholinesterase, obtained from Sigma-Aldrich 
Ltd. (type III, lyophilized powder, 425 U/mg, 687 mg/protein from 
the brain of electric eel) was dissolved in 1 ml of PBS buffer (50 mM, 
pH–8) to make 100 U/ml stock solution and further diluted with 
buffer to get 0.1 U/ml enzyme and used for inhibition studies. Assay 
based on Ellman's reagent, was modified to measure the 
acetylcholinesterase inhibition. The assay contained 1 ml of mixture 
of 0.25 mM Acetylthiocholine Iodide and 0.25 mM DTNB in 50 mM 
sodium phosphate buffer pH 8 and 0.1U of AChE and incubated for 
20 min. The final volume was adjusted to 3 ml with 50 mM sodium 
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phosphate buffer pH 8. The enzymatic reaction of AChE was the 
hydrolysis of the acetyl group of ASCh and gave thiocholine (SCh) as 
the product and reacts with DTNB to form 5-thionitrobenzoate, a 
colored anion, which absorbed at 412 nm. The 1 µl of 0.1 U/ml AChE 
in 50 mM PBS buffer (pH 8) was added to the Ochna obtusata DC. 
Extracts in different concentrations and incubated for 10 min and 20 
µl substrate was added, the absorbance was taken after 20 min. The 
effect of extracts on acetylcholinesterase activity (%) was calculated 
as the change in absorbance in a sample, when compared to the 
change in absorbance in blank wells (average, n=3). Spontaneous 
hydrolysis was subtracted from the rate of reaction [38-42].  
α-Glucosidase inhibition assay 
Plant extracts were pre-incubated with 10μg enzyme equivalents for 5 
min and tested for activity of the enzyme by adding 100μl of the 
substrate, 0.1 mM ρ-nitrophenyl-α-D-glucopyranoside (α-glucosidase) 
and incubated at 35 °C for 10 min. The products were examined using 
spectrophotometrically [43-44]. The percent of inhibitions of the 
enzyme was calculated in relation to the activity without plant extracts 
(taken as 100%). Additional blank incubations with only plant extract 
but without enzyme source were also run. The final inhibitions shown 
by the extract were compared with the standard drug, acarbose. The 
concentration of the extract required to inhibit the activity of the 
enzyme by 50 % (IC50) was calculated. Experiments were performed in 
duplicates, and IC50 values were calculated [45].  
Calculation of scavenging activity 
The percentage of scavenging/Inhibition activities of free radicals or 
target enzymes was calculated using the following formula:  
% scavenged free radicals = [(A0-A1)/A0] x 100 
where, A0 was the absorbance of the control, and A1 was the 
absorbance in the presence of the samples, and all the experiments 
were conducted for three times and the average taken and the 
standard error was calculated using Sigma stat 3.1 version and graphs 
were plotted using Sigma plot 9. The total antioxidant activity was 
compared to the ascorbic acid equivalents using standard graph. 
RESULTS AND DISCUSSION 
Total phenol and antioxidant assay 
The results of the present investigation illustrated that the extracts 
of Ochna obtusata DC., used for various human ailments, was proved 
to possess beneficial biological activities in the prevention of free 
radical generated diseases including α–glucosidase and 
acetylcholinesterase activities. The phenolic compounds were 
estimated in alcoholic and decoction water 400±1 and 420±1.5 mg 
GAE/dried leaf of Ochna obtusata DC. The total antioxidant activity 
of the extracts calculated based on the formation of molybdenum 
complex which measured spectroscopically at 695 nm and 
represented as equivalents of ascorbic acid (EAA). The total 
antioxidant capacity of the alcoholic extract or decoction was found 
to be 240±0.5 mg or 100.6±0.3 mg EAA/g plant material.  
Based on the preliminary test, it was confirmed that the extracts were 
possessed a good quantity of phenols and better antioxidant activity in 
ethanol as well as decoction. Hence, the extracts were further evaluated 
for pharmacologically important and specific radicals and the scavenging 
effects on Reactive Oxygen Species (ROS), Lipid Peroxides (LPO) and 
Reactive Nitrogen Species RNS including inhibitory studies of Acetyl 
cholinesterase (AChE) and α-glucosidase (AG). 
 
Table 1: IC50 values* for scavenging of ROS and Acetylcholinesterase and α-Glucosidase inhibition activity of Ochna obtusata DC.extracts 
S. No. Name of the radical scavenged/enzyme inhibition Alcoholic extract (μg/ml) Decoction (μg/ml) Standards 
1 DPPH radical 0.3±0.01 90±5.1 2.5±2.3a* 
2 Hydrogen peroxide 45±2.1 92±1.3 15±1.03a* 
3 Hydroxyl ion 22±2.3 >200 25±0.9a* 
4 Nitric Oxide 43±0.86 82±1.2 17±1.06a* 
5 Anti-Lipid peroxide 4.37±0.5 1.68±0.3 6±0.04a* 
6 Acetyl cholinesterase 0.5±0.2 40±2.12 7.5±2.03b* 
7 α-Glucosidase 3.5±.04 45±3.03 17.5±1.9c* 
*IC 50 values calculated as mean of triplicates, represented in micrograms of gallic acid equivalents of plant extracts. a, Ascorbic acid; b, Syldenaphyl 
citrate; c, Acarbose 
All the assays were carried out in triplicate. The results are expressed as mean values and standard error or standard deviation (SD). The 
differences between the extracts were analyzed using one-way analysis of variance (ANOVA), followed by Tukey’s HSD Test with α≤ 0.05. 
 
DPPH scavenging activity 
The test samples of Ochna obtusata DC.showed good DPPH radical 
scavenging activity. But the IC50 values from the respective graph 
elucidating that alcohol extract inhibited very strongly than decoction 
(fig. 1).  
 
 
Fig. 1: DPPH radical scavenging activity of Ochna obtusata DC. 
Alcoholic extract (OBAL) and Ochna obtusata DC.decoction 
(OBD). Standard compound, ascorbic acid was used as drug 
control. Concentrations were mentioned as gallic acid 
equivalent (GAE) µg/ml. The experiments were conducted in 
triplicates and the differences between the extracts were 
analyzed using one-way analysis of variance (ANOVA), followed 
by Tukey’s HSD Test with α≤ 0.05 
The IC50 values of alcohol extract, decoction and gallic acid are 
0.3±0.01µg/ml, 90±5µg/ml and 2.52±2µg/ml respectively (table 1). 
This explains that alcohol extract is more potent in scavenging DPPH 
radicals generated in vitro than decoction and even commercial 
antioxidant compound (fig. 1). 
Hydrogen peroxide scavenging assay 
The leaf extracts executed a weak reducing capacity of extracts on 
the decomposition of H2O2 in a concentration-dependent pattern 
(fig. 2) at moderately high concentrations. Hydrogen peroxide is a 
weak oxidizing agent and can inactivate few enzymes directly, 
usually by oxidation of essential thiol (-SH) groups. It is therefore 
biologically advantageous for cells to control the amount of 
hydrogen peroxide that is allowed to accumulate. Two types of 
enzymes exist to remove hydrogen peroxide within cells namely 
catalases and the peroxidases which lead to ground state oxygen 
without any singlet oxygen. The extract might substantiate the 
enzymes during pathogenesis and helps in the decomposition of 
H2O2 which are believed to provide protection of health. In this 
event, it was noted that alcoholic extract with IC50 of 45±2µg/ml GAE 
was efficient over the decoction (IC50 of 92±1µg GAE) (table 1). 
Hydroxyl radical scavenging assay 
The ethanol extract and decoction of Ochna obtusata DC.leaves 
exhibited the scavenging activity of site-specific hydroxyl radicals in 
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concentration-dependent pattern. It is well observed that the 
ethanolic extract was the most active over the decoction as it was 
shown in fig. 3. In this assay, alcoholic extract with IC50 of 22±2 µg 
GAE was efficient over the decoction (IC50–more than 200 µg GAE) in 
scavenging site-specific hydroxyl radical (table 1). 
 
 
Fig. 2: Hydrogen peroxide scavenging activity of Ochna obtusata 
DC. Alcoholic extract (OBAL) and Ochna obtusata DC.decoction 
(OBD). Standard compound, ascorbic acid was used as drug 
control. Concentrations were mentioned as gallic acid 
equivalent (GAE) µg/ml. The experiments were conducted in 
triplicates and the differences between the extracts were 
analyzed using one-way analysis of variance (ANOVA), followed 
by Tukey’s HSD Test with α≤ 0.05 
 
 
Fig. 3: Hydroxyl radical scavenging activity of Ochna obtusata 
DC. Alcoholic extract (OBAL) and Ochna obtusata DC.decoction 
(OBD). Standard compound, ascorbic acid was used as drug 
control. Concentrations were mentioned as gallic acid 
equivalent (GAE) µg/ml. The experiments were conducted in 
triplicates and the differences between the extracts were 
analyzed using one-way analysis of variance (ANOVA), followed 
by Tukey’s HSD Test with α≤ 0.05 
 
Nitric oxide (NO) scavenging  
Nitric oxide (NO) is a potent pleiotropic mediator of physiological 
processes such as smooth muscle relaxation, neuronal signaling, 
inhibition of platelet aggregation and regulation of cell-mediated 
toxicity. It is a diffusible free radical which plays many roles as an 
effect or molecule in diverse biological systems including neuronal 
messenger, vasodilation and antimicrobial and antitumor activities. 
It has been suggested that NO play important role in the 
pathogenesis of inflammation and bowel disease. Thus, the present 
study offers scientific evidence for the use of the plant in the 
indigenous system in inflammatory conditions. The alcoholic extract 
shown significantly more efficient inhibition on the production of 
nitric oxide in the in vitro system when to compare to decoction with 
IC50 of 43±1 and 82±1 µg/ml EAA respectively (table 1& fig. 4). 
Anti-lipid peroxidation assay 
Protection against free radical-induced lipid peroxidation of 
membranes by the extracts might be found application in the use 
against inflammatory diseases. The alcoholic extract and decoction 
of Ochna obtusata DC. inhibited the FeCl3 induced lipid peroxidation. 
The hydroxyl radicals generated in this system is highly effective 
and can damage biological molecules when it reacts with 
polyunsaturated fatty acid moieties of cell membrane phospholipids 
and results into lipid hydroperoxides. 
 
 
Fig. 4: Nitric oxide scavenging activity of Ochna obtusata DC. 
Alcoholic extract (OBAL) and Ochna obtusata DC.decoction 
(OBD). Standard compound ascorbic acid was used as drug 
control. Concentrations were mentioned as gallic acid 
equivalent (GAE) µg/ml. The experiments were conducted in 
triplicates and the differences between the extracts were 
analyzed using one-way analysis of variance (ANOVA), followed 
by Tukey’s HSD Test with α≤ 0.05 
 
Lipid hydroperoxide further decomposed into alkoxy and peroxy 
radicals, eventually triggers formation of carbonyl products such as 
malondialdehyde (MDA). The carbonyl products are responsible for 
DNA damage, generation of cancer and aging related diseases. In the 
present investigation the extracts were potentially prevented the 
formation of MDA which was detected by the formation of TBARS 
(thiobarbituric acid reactive substances). Thus the decrease in the 
MDA level with the increase in the concentration of the extracts 
indicates the role of the extract as an antioxidant (fig. 5). 
Interestingly the decoction has shown good lipid peroxidation 
inhibition with IC50 of 1.68±0.2µg GAE, rather than alcohol extract 
(IC50 of 4.37±0.4 µg/ml GAE) (table 1). 
 
 
Fig. 5: Anti lipid peroxidation activity of Ochna obtusata DC. 
Alcoholic extract (OBAL) and Ochna obtusata DC.decoction 
(OBD) in rat liver tissue homogenates. Standard compound 
ascorbic acid was used as drug control. Concentrations were 
mentioned as gallic acid equivalent (GAE) µg/ml. The 
experiments were conducted in triplicates and the differences 
between the extracts were analyzed using one-way analysis of 
variance (ANOVA), followed by Tukey’s HSD Test with α≤ 0.05 
 
Acetyl cholinesterase inhibition assay 
Acetyl cholinesterase inhibition activity 
Alzheimer’s disease (AD) is associated with significant losses in 
cholinergic neurons and decreased concentrations of the 
neurotransmitter, acetylcholine, which is involved in learning and 
memory processes. Acetyl cholinesterase inhibitors (AchEI) exert 
pharmacologic effects by increasing availability of intra synaptic 
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acetylcholine in the presence of intact cholinergic neurons by 
inhibiting the cholinesterase enzyme from breaking down 
acetylcholine, increasing both the level and duration of action of the 
neurotransmitter acetylcholine. They are used medicinally to treat 
myasthenia gravis (increase neuromuscular transmission), 
Dementia and as an antidote to anticholinergic poisoning in addition 
to AD. Their role in cognitive enhancement appears to be mediated 
through an anti-inflammatory effect, independent of their 
cholesterol-lowering properties. However, the ‘cholinergic anti-
inflammatory pathway’ provides a physiological mechanism linking 
acetylcholine with inhibition of inflammation. Increasing evidence 
now points towards an anti-inflammatory role for AChEIs through 
action against free radicals or through decreasing release of 
cytokines from activated microglia in the brain and blood.  
 
 
Fig. 6: Anti-acetyl cholinesterase activity of Ochna obtusata DC. 
Alcoholic extract (OBAL) and Ochna obtusata DC.decoction 
(OBD). Concentrations were mentioned as gallic acid equivalent 
(GAE) µg/ml. The experiments were conducted in triplicates 
and the differences between the extracts were analyzed using 
one-way analysis of variance (ANOVA), followed by Tukey’s HSD 
Test with α≤ 0.05 
 
α-Glucosidase inhibition activity 
Controlling blood sugar is a measure for the prevention of diabetes. 
Natural resources provide a huge and highly diversified chemical 
bank from which we can explore for potential therapeutic agents by 
bioactivity-targeted screening. α-glucosidase inhibitors inhibit the 
enzyme in the gut, which restrains the liberation of glucose from 
oligosaccharides and thereby reduces the postprandial glucose 
levels. In type II diabetic patients, it enhances the complexity of 
disease as it liberates glucose from carbohydrates [25, 46]. The 
present investigation revealed that the alcoholic extract Ochna 
obtusata DC. is strongly inhibited the activity of glucosidase with the 
IC50 of 3.5±0.41µg when to compare to decoction and standard α-
glucosidase inhibitor (acarbose) with IC50 of 45±3.03 and IC50 of 
17.5±1.9µg respectively (table 1 & Fig.7). Hence, the ethanol extract 
is highly beneficial as oral antidiabetic medicine.  
[ 
 
Fig. 7: α-Glucosidase inhibitory activity of Ochna obtusata DC. 
Alcoholic extract (OBAL) and Ochna obtusata DC.decoction 
(OBD) in rat liver tissue homogenates. Standard compound 
acarbose was used as drug control. Concentrations were 
mentioned as gallic acid equivalent (GAE) µg/ml. The 
experiments were conducted in triplicates and the differences 
between the extracts were analyzed using one-way analysis of 
variance (ANOVA), followed by Tukey’s HSD Test with α≤ 0.05 
The present study revealed that the extracts of Ochna obtusata DC. 
were highly significant in the inhibition of AChE (fig. 6) and proved 
its efficacy as a protective medicament. The alcoholic extract, as well 
as decoction, were efficient in inhibition of acetylcholinesterase with 
the IC50 of 0.5±0.2 and40±2.12 µg/ml of GAE (table 1) respectively. 
CONCLUSION 
The anti-oxidative property of Ochna obtusata DC.ethanol extract 
and decoction obtained from leaves were proved on various 
oxidizing radicals’ viz., hydrogen peroxide, hydroxyl (site specific) 
and nitric oxide along with DPPH assay systems. Inhibitory activity 
of α-glucosidase plays key role in managing the type II diabetes and 
the leaf extract may help in the decreasing sugar level during 
postprandial condition. Acetylcholinesterase inhibition activity may 
help in controlling neurodegenerative diseases which might help in 
controlling Alzheimer’s disease. Hence, the present investigation 
infers that the extracts can be used as a source of natural 
antioxidants with potential application to reduce oxidative stress 
with health benefits.  
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